"10.1371_journal.pone.0017770","plos one","2011-03-14T00:00:00Z","Thomas Duning; Hagen Schiffbauer; Tobias Warnecke; Siawoosh Mohammadi; Agnes Floel; Katja Kolpatzik; Harald Kugel; Armin Schneider; Stefan Knecht; Michael Deppe; Wolf Rüdiger Schäbitz","Department of Neurology, University Hospital Muenster, Muenster, Germany; Department of Clinical Radiology, University Hospital Muenster, Muenster, Germany; Department of Neurology, Charité - Universitaetsmedizin Berlin, Berlin, Germany; Center for Stroke Research Berlin, Charité - Universitaetsmedizin Berlin, Berlin, Germany; Cluster of Excellence NeuroCure, Charité - Universitaetsmedizin Berlin, Berlin, Germany; SYGNIS Bioscience, Heidelberg, Germany; Department of Neurology, EVK Bielefeld, Bielefeld, Germany","Conceived and designed the experiments: TD HS TW HK SK WS. Performed the experiments: TD HS KK HK. Analyzed the data: TD TW SM AF KK MD WS. Contributed reagents/materials/analysis tools: TW SM AF HK AS SK MD WS. Wrote the manuscript: TD WS.","Armin Schneider is an employee of SYGNIS Bioscience and is an inventor on a patent application claiming the use of G-CSF for the treatment of diseases of the central nervous system. Patent Cooperation Treaty WO04058287, Patent Number: 274597, is licensed to the treatment of amyotrophic lateral sclerosis with G-CSF. All other authors reported no financial disclosure and no conflicts of interest. The mentioned conflicts had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and this does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","03","Thomas Duning","TD",11,TRUE,6,4,7,2,TRUE,TRUE,FALSE,0,NA,FALSE
